Genome-wide Chromatin Interactions of the Nanog Locus in Pluripotency, Differentiation, and Reprogramming  by Apostolou, Effie et al.
Cell Stem Cell
ArticleGenome-wide Chromatin Interactions
of the Nanog Locus in Pluripotency,
Differentiation, and Reprogramming
Effie Apostolou,1,2,3,11 Francesco Ferrari,4,11 Ryan M. Walsh,1,2,3 Ori Bar-Nur,1,2,3 Matthias Stadtfeld,1,2,3,9
Sihem Cheloufi,1,2,3 Hannah T. Stuart,1,2,3 Jose M. Polo,1,2,3,10 Toshiro K. Ohsumi,5 Mark L. Borowsky,5
Peter V. Kharchenko,4,6 Peter J. Park,4,7,8,* and Konrad Hochedlinger1,2,3,*
1Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, 185 Cambridge Street, Boston, MA 02114, USA
2Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA
3Howard Hughes Medical Institute and Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Medical School,
7 Divinity Avenue, Cambridge, MA 02138, USA
4Center for Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Boston, MA 02115, USA
5DepartmentofMolecularBiology,MassachusettsGeneralHospital andHarvardMedicalSchool, 185CambridgeStreet,Boston,MA02114,USA
6Division of Hematology/Oncology
7Informatics Program
Children’s Hospital, Boston, MA 02115, USA
8Division of Genetics, Brigham and Women’s Hospital, Boston, MA 02115, USA
9Present address: The Helen L. and Martin S. Kimmel Center for Biology and Medicine, The Skirball Institute of Biomolecular Medicine,
New York University, New York, NY 10016, USA
10Present address: Australian Regenerative Medicine Institute and Department of Anatomy and Developmental Biology, Monash University,
Wellington Rd, Clayton, Vic 3800, Australia
11These authors contributed equally to this work
*Correspondence: peter_park@harvard.edu (P.J.P.), khochedlinger@helix.mgh.harvard.edu (K.H.)
http://dx.doi.org/10.1016/j.stem.2013.04.013SUMMARY
The chromatin state of pluripotency genes has been
studied extensively in embryonic stem cells (ESCs)
and differentiated cells, but their potential interac-
tions with other parts of the genome remain largely
unexplored. Here, we identified a genome-wide, plu-
ripotency-specific interaction network around the
Nanog promoter by adapting circular chromosome
conformation capture sequencing. This network
was rearranged during differentiation and restored
in induced pluripotent stem cells. A large fraction of
Nanog-interacting loci were bound by Mediator or
cohesin in pluripotent cells. Depletion of these pro-
teins from ESCs resulted in a disruption of contacts
and the acquisition of a differentiation-specific inter-
action pattern prior to obvious transcriptional and
phenotypic changes. Similarly, the establishment of
Nanog interactions during reprogramming often
preceded transcriptional upregulation of associated
genes, suggesting a causative link. Our results docu-
ment a complex, pluripotency-specific chromatin
‘‘interactome’’ for Nanog and suggest a functional
role for long-range genomic interactions in the main-
tenance and induction of pluripotency.
INTRODUCTION
Three-dimensional (3D) chromatin architecture is important for
many biological processes including transcriptional regulation.For example, looping between promoter and enhancer or insu-
lator elements controls the transcriptional activation or repres-
sion of genes, respectively (Engel and Tanimoto, 2000; Ling
et al., 2006; Zhao et al., 2006). Although long-range chromatin
interactions have been observed mostly in cis along the same
chromosome (Schoenfelder et al., 2010), they can also occur in
trans between different chromosomes. Interactions in trans are
associated with coregulation of imprinted genes (Zhao et al.,
2006) or genes associated with erythropoiesis (Schoenfelder
et al., 2010), with stochastic selection for monoallelic activation
of the IFN-b locus (Apostolou and Thanos, 2008) and olfactory
genes (Clowney et al., 2012; Lomvardas et al., 2006), and with
activation-induced cytidine deaminase-mediated translocations
(Klein et al., 2011; Rocha et al., 2012). Although the organization
of chromosomes into defined territories was reported three
decades ago (Schardin et al., 1985), the molecular principles of
global chromatin architecture have only recently been explored
with high-throughput technologies such as the Hi-C method
(Dixon et al., 2012; Duan et al., 2010; Lieberman-Aiden et al.,
2009; Sexton et al., 2012; Zhang et al., 2012).
Chromatin organization also plays a role in the control of
pluripotency and cellular differentiation. For instance, pluripo-
tency-associated genes such as Sox2, Nanog, and Klf4 relocate
from the nuclear center to the nuclear periphery upon differenti-
ation ofmouse embryonic stem cells (ESCs) (Peric-Hupkes et al.,
2010). Moreover, the loss of promoter-enhancer interactions at
key pluripotency genes, including Nanog and Oct4, during ESC
differentiation has been associated with silencing of these genes
(Kagey et al., 2010; Levasseur et al., 2008). Proteins involved in
chromatin looping, including CTCF, cohesin, and Mediator, co-
occupy many genomic targets of pluripotency factors (Kagey
et al., 2010; Nitzsche et al., 2011) or directly interact with themCell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc. 699
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therefore cooperate to arrange a higher-order chromatin struc-
ture that maintains pluripotency. Indeed, depletion of Mediator
and cohesin subunits from ESCs results in unscheduled differen-
tiation (Kagey et al., 2010). A more recent study using the Hi-C
technology in mouse and human ESCs and differentiated cells
identified a network of local chromatin-interaction domains, so-
called topological domains, with conserved boundaries among
different species and cell types (Dixon et al., 2012). Although
that report documented important general principles of chro-
matin organization in pluripotent and differentiated cells, a
high-resolutionmapof genome-wide interactions of pluripotency
genes in ESCs is lacking. It also remains unclearwhichmolecules
might be involved in establishing such putative connections, and
whether and how these patterns change upon differentiation.
Forced expression of the transcription factors Oct4, Sox2,
Klf4, and c-Myc is sufficient for endowing somatic cells with
pluripotency, giving rise to induced pluripotent stem cells
(iPSCs) (Takahashi and Yamanaka, 2006). In-depth molecular
analysis of reprogramming intermediates has been achieved
only recently with improved technologies for studying rare and
defined cell populations (Buganim et al., 2012; Golipour et al.,
2012; Polo et al., 2012; Soufi et al., 2012). In addition, molecular
characterization of stable partially reprogrammed iPSC (piPSC)
lines sheds light on the earliest events in cellular reprogramming
(Mikkelsen et al., 2008; Sridharan et al., 2009). Although these
studies reported the reestablishment of an ESC-like transcrip-
tional and epigenetic state, it remains unclear whether, when,
and how the 3D chromatin structure is reset during cellular
reprogramming into iPSCs.
In this study, we have investigated the genome-wide interac-
tion network of the Nanog gene, which is indispensable for
development as well as for the derivation of ESCs (Mitsui et al.,
2003; Chambers et al., 2003) and iPSCs (Silva et al., 2009). We
developed a modified version of circular chromosome con-
formation capture sequencing (m4C-seq) to determine the
genome-wide interaction partners of the Nanog locus in ESCs,
iPSCs, and mouse embryonic fibroblasts (MEFs) at high resolu-
tion. Our study provides the first detailed chromatin-interaction
map of a key pluripotency locus on a genomic scale and offers
mechanistic insights into the regulation of chromatin architecture
during the acquisition and maintenance of pluripotency.
RESULTS
The Nanog Locus Engages in Distinct Genome-wide
Interactions in Pluripotent and Differentiated Cells
We developed a modified version of 4C-seq for unbiased
genome-wide capture of Nanog’s interactions in pluripotent
and differentiated cells (Figure 1A; see Experimental Proce-
dures). In brief, 4C technology is based on the proximity-ligation
principle, in which unknown chromatin loci that interact with a
known ‘‘bait’’ locus (e.g., Nanog) are ligated into chimeric DNA
molecules and then identified by deep sequencing (Dekker
et al., 2002). m4C-seq involves ligation of universal adapters to
the linearized hybrid molecules, followed by ligation-mediated
PCR with an adaptor-specific oligonucleotide and a biotinylated
primer recognizing the Nanog locus. This allows specific enrich-
ment and purification of the Nanog-interacting regions using700 Cell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc.streptavidin beads and avoids the less-efficient recircularization
and inverse-PCR steps of published 4C methods.
To increase confidence in observed interactions, we used bio-
logical replicates, applied multiple filtering and normalization
steps, andadjusted for random ligation events andpossible tech-
nical biases based on a control sample (noncrosslinked genomic
DNA; see Experimental Procedures). Technical replicates gener-
ated by independent ligation, amplification, and sequencing
showed a high level of concordance (Spearman’s rank correla-
tion coefficient z 0.9) (Figure S1A available online). We then
analyzed three independent biological replicates for ESC lines
(R1, V6.5, and KH2-ESC1), MEFs, and fibroblast-derived iPSC
clones previously shown to give rise to entirely iPSC-derived
mice, thus satisfying the most stringent criteria of pluripotency
(Stadtfeld et al., 2010a). The biological replicates of pluripotent
cells showed higher variability than the technical replicates,
as expected, but nevertheless exhibited high correlation
(Spearman’s coefficient z 0.7) (Figures S1A–S1D). However,
MEF replicates showed notably lower correlation (Spearman’s
coefficientz 0.3), suggesting that Nanog may have less-stable
interactions in MEFs, perhaps because the gene is not active.
Unsupervised clustering (Figure 1B) highlighted similarities
between ESCs and iPSCs, which clustered separately from
MEFs. Consistent with this observation, we found extensive
overlap (70%) among the conserved Nanog interactions in
ESCs and iPSCs (Table S1), but much less overlap between
these pluripotent samples and MEFs (<10% of pluripotent
interactions) (Figure 1C). The higher variability in MEF samples
resulted in a smaller set of conserved interactions among repli-
cates (Figures 1C and S1C; Table S1). These results show dis-
tinct Nanog interactomes in differentiated and pluripotent cells.
Given that Nanog is located in a gene-rich genomic region
containing other pluripotency loci, we first examined a 200 kb
window around its promoter. We detected several interaction
partners, including the Nanog enhancer, Aicda, Apobec1, and
Scl2a3 genes (Figure S1E). We obtained reads for 11 out of 12
loci that have previously been tested in ESCs by chromosome
conformation capture (3C) (Levasseur et al., 2008). We also iden-
tified broad interaction domains in distal regions on chromo-
some 6, visualized in the form of a ‘‘domainogram’’ (Figure S2A)
(Bantignies et al., 2011). Randomly selected interactions within
the broad domains were verified by 3D DNA fluorescence
in situ hybridization (FISH) (Figures 1D, 1E, and S2B) and by
3C analysis among single HindIII fragments using independent
cell preparations (Figure S2D). FISH results were independently
confirmed for a subset of nuclei (250 nuclei for three probes in
total) at a higher resolution, which allowed for more accurate
measurement of colocalized signals (<250 nm, Figure S2C).
Broad interaction domains with differential strengths in ESCs
and MEFs are shown in Figure 1F. MEF-derived iPSCs and
ESCs showed similar differential domainogram patterns when
compared to MEFs, suggesting that reprogramming restored
the ESC-specific 3D structure along chromosome 6. Further-
more, cis interaction patterns observed in published Hi-C data
for ESCs (Dixon et al., 2012) exhibited a higher correlation to
those we detected in ESCs and iPSCs than to those in MEFs
(Figure S2E). Together, these data document that Nanog forms
a pluripotency-specific interactome with multiple genomic re-
gions along its entire chromosome in both ESCs and iPSCs.
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Figure 1. Genome-wide Interactions of the Nanog Locus in Differentiated and Pluripotent Cells
(A) Schematic representation of m4C-seq. LM-PCR, ligation-mediated PCR; Strep-beads, streptavidin-conjugated beads; H, HindIII site; N, NlaIII site.
(B) Unsupervised clustering and correlation matrix of pluripotent and differentiated cells (three ESCs, three iPSCs, and three MEFs). Normalized (observed over
expected) m4C-seq signals at individual HindIII fragments are clustered, with Spearman’s correlation (color gradient) and average linkage shown. Fragments
detected in at least three out of nine samples are used.
(C) Venn diagram showing the degree of overlap among the Nanog-interacting HindIII fragments common within each group: ESCs, iPSCs, and MEFs.
(D) Theupperpanels showdetails of domainogramanalysis for broad intrachromosomal interactiondomains (Cntnap2,Anxa4, andan intergenic region) in individual
samples. Regions around broad interaction domains are shown for a representative ESC sample (ESC1 cell line). The centers of interacting domains are marked
in red at the bottom (p value < 0.0001). The dashed horizontal white line indicates the maximum-window-size cutoff. The bottom panels show representative 3D
DNA FISH in ESCs confirming the interaction of Nanog (green fluorescein isothiocyanate [FITC] signals) with each of those domains (magenta Alexa 568 signals).
(E) Boxplot for distances between theNanog locus and the tested domains (n = number of measured nuclei). Intrachromosomal regions between the positive hits
and the bait position were used as negative controls (neg_A and neg_B). p values for the Wilcoxon signed-rank test are reported (see also Figure S2C). Whiskers
extend to the most extreme values within 1.5 times the interquartile range from the upper or lower quartile.
(F) Differential interactions over large domains (domainogram) for ESCs versusMEFs (upper panel) and iPSCs versusMEFs (bottom panel) on chromosome 6. The
green arrow indicates the Nanog position. Top: interacting domains upregulated in MEFs (magenta); bottom: interacting domains upregulated in ESCs or iPSCs,
respectively (green). In the central part, magenta and green marks indicate the regions significantly upregulated (p value < 0.001) in MEFs and ESCs or iPSCs,
respectively. The dashed horizontal white line indicates the maximum-window-size cutoff. All replicates for each cell type are taken into account for computing
the score for differential interactions.
See also Figures S1 and S2 and Tables S1 and S6.
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Figure 2. Detection and Validation of Interchromosomal Associations of the Nanog Locus in Pluripotent and Differentiated Cells
(A) Circos plot for differential interchromosomal interactions in ESCs (green) compared to MEFs (orange) as detected from broad domain analysis using
domainograms (Figure 1F) in each chromosome.
(B) Three interchromosomal Nanog-interacting domains confirmed by 3D DNA FISH in ESCs. The domainograms refer to the ESC1 line and are representative of
other ESCs. Representative 3D DNA FISH images show theNanog alleles (green FITC signals) interacting with each of those domains (left) or their corresponding
negative controls (right) (magenta Alexa 568 signals). The boxplots report 3D DNA FISH results (n = number of nuclei; p =Wilcoxon test p value) (whiskers are as in
Figure 1E). Negative controls were selected in regions within 2 Mb of the targets.
(C) 3C PCR confirmation of selected differential interchromosomal interactions of theNanog locus in ESCs and iPSCs versusMEFs. For each primer pair, the PCR
signal was calculated relative to the corresponding signal in ESCs (‘‘Relative 3C Interaction’’) after normalization with the PCR signal of primers designed at the
bait locus (see Table S6). Error bars indicate SD (n = 3 technical replicates). All 3C PCR products were isolated and analyzed by Sanger sequencing.
(D) Domainogram details for differential interactions around XPC and Ugg2t, which were found to interact with Nanog preferentially in ESCs. Top (magenta) and
bottom panels (green) refer to interaction enrichment in MEFs and pluripotent cells, respectively. 3D DNA FISH results for the two regions are shown in the
boxplot, similarly to (B) (whiskers are as in Figure 1E).
See also Figure S2 and Tables S2 and S6.
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Interchromosomal Associations
Many of the detected contacts were found to be trans interac-
tions of Nanog with other chromosomes (Figure 2A and Table
S1). Although previous studies using conventional 4C-seq proto-
cols did not detect such a high number of trans associations
(Simonis et al., 2006, 2009), our results are consistent with a
similar 4C adaption termed ‘‘enhanced 4C’’ (e4C) (Schoenfelder
et al., 2010). We believe that m4C-seq and e4C approaches
using universal adapters and streptavidin-based purification
and enrichment of the bait locus enable greater sensitivity. The
high number of observed interchromosomal interactions is
further supported by the tendency of the Nanog locus to localize702 Cell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc.on the edge or outside of its chromosome territory (Figure S2F).
Moreover, reanalysis of recently published Hi-C data from
mouse ESCs (Dixon et al., 2012) showed that over 60% of
Nanog’s trans interactions overlapped significantly with our
m4C-seq interactions in ESCs and iPSCs, but not with those in
MEFs (Figure S2G). Selected interacting regions in ESCs, local-
ized on three different chromosomes, were tested by 3D DNA
FISH in ESCs, and they showed closer proximity to the Nanog
locus compared with noninteracting regions on the respective
chromosomes (Figure 2B).
The distribution of broad differential intra- and interchromo-
somal interaction domains in pluripotent (ESCs) versus dif-
ferentiated (MEFs) cells is visualized in Figure 2A. In addition,
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Figure 3. Nanog-Interacting Regions Are Enriched for Open Chromatin Features and Pluripotency-Factor Binding in Pluripotent Cells
(A) Distribution of the Nanog-interacting loci detected at single-fragment level in each sample. Log ratios of observed over expected fragments in different
genomic regions show a consistent overrepresentation of interactions in genes and surrounding regions (20 kb upstream or downstream).
(B) Association of theNanog-interacting regions with replication timing (RT). Genomic segmentswere divided into five groups (from early to late) based on their RT
data in each cell type (Hiratani et al., 2010). The median association of interacting fragments (observed over expected log ratio) across biological replicates is
plotted as a heatmap.
(C) Association of conserved Nanog interactions within each cell type (ESCs, iPSCs, or MEFs) with active or repressive chromatin features. Conserved Nanog
interactions were identified by gene-level analysis; ChIP peaks in ESCs were linked to genes when overlapping with a 5 kb-to-+1 kb window at transcriptional
start sites. The barplots show the significance of association between Nanog-interacting genes and genes enriched for a given mark, tested independently for
each cell type. The number and the percentage of interacting genes with a given chromatin mark are reported for each bar.
(D and E) Similar analyses of association to genes bound by pluripotency transcription factors in ESCs (D) and genes bound by components of cohesin and
Mediator complexes and CTCF in ESCs (E) are shown.
See also Figure S3 and Table S3.
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are reported in Table S2 and shown in Figure S1B. We con-
firmed several of the differential interactions between MEFs
and ESCs, either by 3C (Figure 2C) or 3D DNA FISH analysis
(Figure 2D) using independent cell preparations. Collectively,
these results show that Nanog forms a complex genomic
interaction network with multiple chromosomes that differs
between pluripotent and differentiated cells and is restored in
iPSCs.Nanog-Interacting Loci Are Enriched for Open
Chromatin Features as well as Binding Sites for
Pluripotency Factors, Cohesin, and Mediator
To determine whether Nanog-interacting loci share common
genomic features, we compared our results with published
data (Table S3). We first noticed consistent enrichment for
gene bodies and surrounding regulatory regions among
interactions in ESCs, iPSCs, and MEFs (Figure 3A), as well as
for early-replicating domains, which typically exhibit an openCell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc. 703
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Genome-wide Interactions of the Nanog Locuschromatin structure (Figure 3B). The latter correlation is consis-
tent with the fact that Nanog replicates early in both cell types
despite its transcriptional silencing in MEFs (Hiratani et al.,
2008, 2010).
We next examined chromatin features of pluripotent cells
including histone marks (Table S3) and DNase I hypersensitivity
among Nanog-interacting genes using data from the Encyclo-
pedia of DNA Elements project (ENCODE Project Consortium,
2011). Nanog-interacting genes in pluripotent cells were
enriched for the activating histone marks H3K4me3 and
H3K4me2 and enhancer marks (H3K27ac, H3K4me1, and
p300), as well as for DNase I-hypersensitive sites characterizing
open chromatin areas (Figures 3C and S3A). A weak correlation
was also detected for the repressive H3K27me3 mark and
for bivalent promoters (p value < 0.05 in ESCs and iPSCs).
However, we were unable to detect significant and consistent
enrichment for binding sites of the Polycomb complex, which
deposits H3K27me3 (Figures 3C and S3A). Thus, Nanog
interacts mostly with active genes and regulatory elements in
pluripotent cells.
To gain mechanistic insights into how the identified interac-
tions are established, we searched for enrichment of pluripo-
tency transcription factor binding sites among the Nanog-
interacting loci using published chromatin immunoprecipitation
sequencing (ChIP-seq) data sets (Table S3). Indeed, target sites
for Esrrb, Klf4, c-Myc, and Sox2 were among the most consis-
tently and significantly enriched sequences, whereas enrich-
ment of Nanog and Oct4 targets varied across data sets (Figures
3D and S3B). We also found a pluripotency-specific association
with binding of additional factors of the pluripotency network
(Chen et al., 2008), including Tcf3, Tcfcp2l1, Nr5a2, and Zfx (Fig-
ures 3D and S3B). Together, these data show that genes inter-
acting with Nanog in ESCs and iPSCs are strongly enriched for
binding of essential pluripotency factors. It remains to be tested
whether this result reflects that coregulated genes are spatially
connected or that some of these factors are actively involved
in chromatin looping.
We also examined occupancy of cohesin,Mediator, andCTCF
molecules, proteins reported tomediate long-range interactions,
among the ESC-specific contacts (Table S3). We found a sig-
nificant association of Nanog interactions in pluripotent cells
with binding of the Mediator (Med1 and Med12) and cohesin
(Smc1a, Nipbl, and Smc3) complexes and a less-consistent
correlation with CTCF binding depending on the data set (Fig-
ures 3E and S3C). Collectively, these results suggest that key
pluripotency transcription factors might collaborate with mole-
cules known to mediate promoter-enhancer looping and general
chromatin organization to establish the observed pluripotency-
specific Nanog interactome.
Nanog Interactions Are Dependent on Mediator and
Cohesin Subunits in ESCs
Wenext asked howmany of those regionswere indeed bound by
the Mediator and cohesin complexes in ESCs. To this end, we
performed ‘‘4C-ChIP-seq’’ (Figure 4A), wherein ChIP for the
Med1 and Smc1 proteins was carried out before sequencing
of the Nanog-centered m4C libraries (Figure S4A and Experi-
mental Procedures). Loci bound by Med1, Smc1, or both
accounted for about 40% of all ESC-specific interactions (Fig-704 Cell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc.ure 4B; Table S4). These data reinforce the results of our associ-
ation analysis with published data and show that a large portion
of the ESC-specific Nanog interactions involve the Mediator and
cohesin complexes.
To test whetherNanog interactions require the Mediator or the
cohesin complex, we performed m4C-seq in ESCs transduced
with lentiviral vectors expressing short hairpin RNAs (shRNAs)
against Smc1a or Med1 (Figures 4A and S4B; Table S6). Chro-
matin was isolated 5 days after viral transduction, when protein
levels were substantially reduced (Figure S4B) but before the
onset of differentiation, as assessed by their undifferentiated
morphology (Figure S4C) and the ESC-like messenger RNA
(mRNA) and protein levels of several pluripotency factors (Fig-
ures 4C, S4D, and S4E). Importantly, Nanog’s promoter-
enhancer interaction was already disrupted at day 5 of Med1
or Smc1a knockdown (KD) (Figure 4D), although Nanog tran-
scription was still detectable by RT-PCR (Figure 4C) and by the
presence of Pol II phospho-Ser2 on the Nanog promoter (Fig-
ure S4F). Med1- and Smc1a-mediated Nanog interactions
were severely reduced or completely abrogated in the day 5
KD 4C-seq samples (Figure 4E). Loss of chromatin contacts
was confirmed by DNA FISH for one of the interacting candidate
loci (Figure 4F). RNA sequencing (RNA-seq) analysis of Med1
and Smc1a KD ESCs confirmed downregulation of pluripo-
tency-related genes and upregulation of differentiation-related
genes by day 8, whereas these changes were less evident on
day 5 (Figure S4G). The altered transcriptional profiles of our
KD cells at day 8 resembled those of previously published
ESCs infected with shRNAs against Med12 (another Mediator
subunit) or Smc1a (Kagey et al., 2010) (Figure S4H). The faster
kinetics of differentiation upon Med12 and Smc1a KD reported
in that study probably resulted from a more efficient depletion
with a different vector system. Remarkably, the m4C-seq pro-
files of KD ESCs indicated that the majority of the ESC-specific
interactions were lost (Figures 4H and S4I), whereas many of
the MEF-specific interactions were established, presumably in
a Med1- or Smc1a-independent manner (Figures 4G and 4H).
Thus, Smc1a and Med1 depletion led to rearrangement of chro-
matin from a pluripotent- to a differentiation-specific state, even
though cells still showed phenotypic and transcriptional features
of the pluripotent state.
The Nanog Interactome Undergoes Dramatic Changes
during Somatic Cell Reprogramming
Given that iPSCs have reset the Nanog interactome from a
somatic to a pluripotent state, we assessed when chromatin
rearrangements occur during reprogramming and how these
relate to gene-expression changes. Specifically, we compared
the kinetics of chromatin looping with gene expression using
piPSC lines and sorted SSEA1+ intermediates at different stages
of reprogramming (Figure 5A). Importantly, both piPSCs and
SSEA1+ intermediates have exited the somatic state and are
poised to form iPSCs under different conditions, consistent
with previous observations (Figures S5A and S5B) (Sridharan
et al., 2009; Stadtfeld et al., 2008). In further agreement with
those previous reports, we found that Nanog is not yet ex-
pressed in piPSCs, whereas it is gradually upregulated during
mid-to-late stages of reprogramming (Figure 5B). Surprisingly,
3C analysis revealed that looping between the Nanog enhancer
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Figure 4. Mediator and Cohesin Coordinate Nanog’s Genomic Interactions in Pluripotent Cells
(A) Two-pronged strategy for testing the role of candidate proteins in the Nanog interactome in ESCs.
(B) Venn diagram depicting the overlap of Nanog-interacting HindIII fragments detected by m4C-ChIP-seq for either Med1 or Smc1a compared to m4C-seq in
ESC line ESC1.
(C) RT-PCR analysis for pluripotency genesNanog andPou5f1 in ESCs treatedwith shRNAs againstMed1 orSmc1 for 5 (d5) or 8 days (d8). Error bars indicate SD
(n = 3 technical replicates). m4C-seq analysis was performed on day 5, before downregulation of Nanog or Pou5f1 and apparent differentiation of cells.
(D) 3C PCR quantifying the interaction frequency between the Nanog promoter and enhancer in control ESCs and in ESCs harvested 5 (d5) or 8 days (d8) after
knocking downMed1 or Smc1a. For each primer pair, the PCR signal was normalized to the PCR signal of primers designed at the bait locus (see Table S6). Error
bars indicate SD (n = 3 technical replicates).
(E) Boxplot reporting the relative change in 4C-seq normalized signal of the 4C-ChIP selected fragments compared to ESC1 (log2 ratio) (whiskers are as in
Figure 1E).
(F) Top: domainogram details showing the interaction ofNanogwith theUggt2 locus in control ESC1 and its disruption in Smc1a KD ESC1.Middle: representative
DNA FISH photos forNanog (FITC signal) andUggt2 (magenta signal) in control or Smc1aKDESCs. Bottom: boxplot for distances between theNanog andUgg2t
as measured by DNA FISH (whiskers are as in Figure 1E). The difference is significant (Wilcoxon test).
(G) Unsupervised clustering of samples is performed as in Figure 1B with the addition of the ESC samples for Med1 or Smc1a KD.
(H) Heatmap showing the relative change in m4C-seq signal for the set of 4C fragments selected as differential interactions between ESCs and MEFs, clearly
showing that the pluripotency-specific interactions have been lost in the Med1 or Smc1a KD sample. The rows refer to individual HindIII fragments, and the
columns are different 4C-seq samples. The color refers to standardized values across samples (Z score) for log-transformed normalized 4C read counts.
See also Figure S4 and Tables S4 and S6.
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Genome-wide Interactions of the Nanog Locusand promoter was established in both piPSC and in SSEA1+
intermediates before detectable transcriptional activation of
Nanog (Figure 5C). We extended this analysis by performing
3C analysis in piPSCs forOct4,Phc1 and Lefty1,which form pro-
moter-enhancer loops in ESCs (Figure S5C) (Kagey et al., 2010).
Whereas Phc1 already exhibited looping and expression in
piPSCs, Oct4 had neither initiated looping nor activated ex-
pression. In contrast, Lefty1 had initiated looping, but not yet
expression, akin to the Nanog locus. These results support the
conclusion that the looping at the examined pluripotency-asso-ciated genes precedes, but is not sufficient for, transcriptional
activation in the context of cellular reprogramming.
On a genome-wide scale, m4C-seq analysis of piPSCs and
SSEA1+ intermediates showed that both cell populations had
lost a large fraction of the MEF-specific interactions and had
gained a small number of ESC-specific interactions (Figures
5D, S5D, and S5E). Unexpectedly, we also observed a number
of reprogramming-specific interactions detectable neither in
MEFs nor in iPSCs (Table S5). Transient interactions were vari-
able among SSEA1+ samples from independent reprogrammingCell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc. 705
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Figure 5. Dynamic Change of Nanog Interactome during Cellular Reprogramming into iPSCs
(A) Isolation and study of reprogramming intermediates and piPSCs.
(B) RT-PCR analysis forNanogmRNA in indicated cell populations. TheNanog expression is normalized overGapdh (% ofGapdh). The error bars indicate SD (n =
3 technical replicates). Late intermediates include SSEA1+ cells from day 9 and day 12.
(C) 3C analysis of relative interaction frequency between theNanog promoter and enhancer during reprogramming and in the piPSCs. The PCR signal is relative to
ESCs (‘‘Relative 3C Interaction’’) after normalization with bait-locus primers (see Table S6). Error bars represent SD (n = 3 technical replicates).
(D) Boxplot for the standardized interaction strength for differentiation-specific fragments (whiskers are as in Figure 1E). The fragments were selected as dif-
ferential fragments upregulated in MEFs versus ESCs. Five groups of samples are shown: ESCs, iPSCs, SSEA1+ intermediates, piPSCs, and MEFs. SSEA1 in-
termediates and piPSCs show an intermediate interaction strength between strongerMEFs andweaker ESCs and iPSCs. For each fragment, the log-transformed
normalized 4C read counts are standardized by subtracting the mean value across all samples, then dividing over SD (Z score) (see also Figure S5D).
(E) Pie charts showing the number of genes, which have established (gain) interactions with Nanog during the transition from MEFs to piPSCs (upper panel) or
from piPSCs to iPSCs (lower panel). Genes are grouped based on the change of expression detected by microarray data (false discovery rate = 0.05; fold
change = 1.3) (Sridharan and Hochedlinger data sets, Table S3 and Figure S5G). Up/Down, up-/downregulated genes in the transition from MEFs to piPSCs
(upper panel) or from piSPCs to iPSCs (lower panel); Up-/Down-next (for the upper panel only), represents up-/downregulated genes in the next stage, i.e., the
transition frompiPSCs to iPSCs (see also F); NC, geneswithout a statistically significant change in expression. The number of genes and percentage over the total
are indicated. We found significant enrichment in the ‘‘Up-next’’ group (one-tailed Fisher’s exact test, p = 0.001). Gene-level interactions detected in all piPSC
replicates and in none of the MEFs were used.
(F) Heatmap showing expression of Nanog-interacting genes gained in the MEF-to-piPSC transition, as in (E). Rows are genes, and columns are microarray
samples (Table S3). Expression-pattern groups were defined as in (E) and marked accordingly with the side color bar. Some genes showed significant upre-
gulation in both theMEF-to-piPSC and the piPSC-to-iPSC transitions. In this case, they were assigned to the ‘‘Up-next’’ group as well. The statistically significant
enrichment in the ‘‘Up-next’’ pattern is confirmed even if these genes are assigned to the ‘‘Up’’ group. The heatmap shows standardized gene-expression levels
across samples (Z score).
(G) Association of conservedNanog-interacting genes in piPSCswith H3K4me3, H3K27me3, and pluripotency transcription factors binding in the same cell type.
The number and percentage of interacting genes with ChIP enrichment is reported for each bar. The analysis criteria is similar to that in Figure 3.
See also Figure S5 and Table S5.
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cell RT-PCR of Figure S5F and Polo et al., 2012). We therefore
focused on piPSCs, which are of clonal origin and hence more
homogeneous. Notably, these transient interactions in piPSCs706 Cell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc.(Table S5) were preferentially associated with pluripotency-
rather than differentiation-related genes (p value = 0.014).
Thus, forced expression of reprogramming factors readily extin-
guished fibroblast-specific interactions and induced a large
Cell Stem Cell
Genome-wide Interactions of the Nanog Locusnumber of transient chromatin interactions enriched for pluripo-
tency-associated genes.
We next correlated the reorganization of Nanog’s interactome
during reprogramming with transcriptional changes of associ-
ated genes. Notably, more than 50% of genes that established
interactions with Nanog during the transition of MEFs into
piPSCs became transcriptionally upregulated in piPSCs (‘‘Up’’)
or at the subsequent (iPSC) stage (‘‘Up-next’’) (Figures 5E, 5F,
and S5G). These results extend, to a genome-wide level, our pre-
vious observations that the gain of Nanog-centered chromatin
contacts during early reprogramming coincideswith or precedes
transcriptional changes of genes. Unexpectedly, the interactions
gained during the piPSC-to-iPSC transition showed a weaker
correlation with transcriptional changes, suggesting a lesser
impact of Nanog interactions on gene expression during the
late stages of reprogramming. We conclude that Nanog’s chro-
matin associations during early stages of reprogramming mostly
involve genes that are either immediately upregulated or poised
for activation in iPSCs.
To investigate which molecules might mediate Nanog’s
interactions during reprogramming, we compared m4C-seq
results on piPSCs with published ChIP-chip data of reprogram-
ming factors and histone modifications in the same cell type
(Sridharan et al., 2009). This analysis revealed a positive correla-
tion with the active histone mark H3K4me3 and a significant
association of Nanog’s interacting loci with Klf4 binding, further
supporting its possible role in regulating long-range chromatin
interactions (Figures 3D and 5G). Thus, forced expression of
Oct4, Sox2, Klf4, and c-Myc induces reorganization of chro-
matin architecture and facilitates interactions of the Nanog locus
with other Klf4 target genes, as well as with open chromatin
domains.
Reprogramming Factors andMediator Cooperate during
the Establishment of Nanog-Centered Interactions
To investigate whether Mediator and cohesin are involved in the
acquisition of pluripotency, we assayed the potential to generate
iPSCs from reprogrammable MEFs when subunits of Mediator
(Med1 and Med12) and/or cohesin (Smc1a, Smc3, and Rad21)
were depleted (Figure S6A). Indeed, KD of Mediator and/or
cohesin components significantly decreased reprogramming
efficiencies (Figure 6A).
Upon KD of Mediator and cohesin components, fewer iPSC
colonies could result from either deficient reprogramming or
immediate differentiation of newly formed iPSCs. To distinguish
between these possibilities, we analyzed early (SSEA1) and late
(EpCam) markers of pluripotency at intermediate stages of re-
programming (Polo et al., 2012). We focused on Med1 KD cells
because Med1 is expressed most differentially between somatic
and pluripotent cells (Figure S6B) (Kagey et al., 2010; Polo et al.,
2012). Figure 6B shows that Med1 KD MEFs gave rise to fewer
SSEA1+ and EpCam+ reprogramming intermediates at day 9 of
reprogramming-factor overexpression. 3C analysis at this time
point showed that Nanog promoter-enhancer looping was not
efficiently established in the absence of Med1, concordant
with decreased transcription (Figure 6C). Together, these data
suggest that Med1 is important for acquiring pluripotency-spe-
cific chromatin loops and gene expression in addition to its
established role in the maintenance of pluripotency.We hypothesized that Med1 might cooperate with reprog-
ramming factors to reorganize 3D chromatin architecture and
to control gene expression during iPSC formation. Coimmuno-
precipitation experiments in piPSCs showed association of
Med1 with the reprogramming factors Oct4, Sox2, and Klf4
(Figure 6D), as well as with Med12 and Smc1 (Figure S6C),
which have previously been reported to interact with Med1 in
ESCs (Borggrefe and Yue, 2011; Kagey et al., 2010). Impor-
tantly, these protein-protein interactions were detected as early
as 48 hr after expression of the reprogramming factors, sug-
gesting an early function. Med1’s interactions with Oct4 and
Sox2 were also confirmed in ESCs (Figure S6C). These results
indicate that Mediator components and pluripotency factors
form a multiprotein complex throughout cellular reprogramming
and in pluripotent cells.
Lastly, we asked how reprogramming factors might collabo-
rate with Mediator and/or cohesin to form chromatin loops
during reprogramming.We investigated the binding of these pro-
teins to three genomic regions (Aicda, Nanog enhancer, and
Slc2a3) found to interact with the Nanog promoter in pluripotent
cells based on m4C-seq data (Figure 6E). This analysis showed
that Klf4, Oct4, Sox2, Med1, and Smc1 were bound to all three
loci in pluripotent cells (Figure S6D). Similarly, the loci that had
already established chromatin loops with the Nanog promoter
(Nanog enhancer and Slc2a3) in piPSC lines were occupied by
all tested factors (Figure 6F). In contrast, Aicda, which interacted
with the Nanog promoter in established iPSCs only, but not yet
in piPSCs, was bound solely by Klf4 in piPSCs. This result sug-
gests that a minimum set of pluripotency proteins may be
required by cohesin and Mediator to bridge distal chromatin
elements.
DISCUSSION
Herein, we provide genetic, biochemical, and bioinformatic evi-
dence that Nanog engages in a pluripotency-specific genome-
wide chromatin network that resolves into a somatic-specific
pattern upon differentiation and resets in iPSCs (Figure 7). This
is the first genome-wide interaction map of a key mouse plurip-
otency gene at high resolution. Our results extend previous
genome-scale transcription factor occupancy and protein inter-
action studies for pluripotency factors (Chen et al., 2008; Kim
et al., 2008) and reveal an unexpectedly complex genomic inter-
actome in pluripotent cells.
We documentNanog promoter interactions with individual loci
as well as broader domains on the same and on different chro-
mosomes. These interactions were stable and conserved among
different pluripotent cell lines, whereas they were less consistent
in MEFs (Figure 7). This finding indicates that pluripotency loci
might engage in less stable and/or more random interactions
in cell types wherein the bait locus is inactive. Alternatively, it
may reflect the heterogeneity of fibroblast populations, which
were used as a proxy for differentiated cells. Of note, almost
half of the conserved interactions found in MEF samples were
also detected in pluripotent cells, indicating a cell-type indepen-
dent network of presumably structural interactions.
A positive correlation between Nanog-centered interactions
and active chromatin marks specifically in pluripotent cells is in
accordance with previous studies showing that active genesCell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc. 707
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Figure 6. Role of Mediator and Cohesin in the Reprogramming of MEFs to iPSCs
(A) Graph comparing the reprogramming efficiency of tetO-OKSM MEFs after infection with empty vector (control) or shRNA vectors (KD) against individual
subunits of Mediator (Med1 and Med12) or cohesin (Smc1a, Smc3, and Rad21) complexes or combinations thereof. The efficiency was calculated as the
ratio of alkaline-phosphatase-positive colonies per starting number of cells. Reprogramming efficiency of control MEFs was set at 1. Error bars indicate SD (n = 3
biological replicates).
(B) Fluorescence-activated cell sorting plots of SSEA1-positive or EpCam-positive cells on day 9 of reprogramming, starting with either wild-type (left) or Med1-
knocked down (KD, right) reprogrammable MEFs. SSEA1 and EpCam were chosen as early or late surface markers of pluripotency, respectively.
(C) RT-PCR (bottom) for Nanog expression and 3C assay (top) for Nanog enhancer-promoter interaction in MEFs, iPSCs, and reprogramming intermediates of
control or Med1 KD MEFs on day 9. The 3C PCR signal was calculated relative to ESCs (‘‘Relative 3C Interaction’’) after normalization with bait-locus primers
(Table S6). Error bars represent SD (n = 2 technical replicates). The RT-PCR Nanog signal was normalized to Gapdh levels, and the error bars indicate SD (n = 4
replicates).
(D) Med1 protein immunoprecipitation (upper panels) in reprogrammable MEFs before (MEF) and after (MEF 48 hr) doxycycline induction and in piPSCs. In the
bottom panel, the interaction of Med1 with Oct4, Sox2, and Nanog was also confirmed in ESCs, this time using antibodies for the reprogramming factors for the
pull-down.
(E) Schematic representation of the genomic regions found to interact in ciswith theNanog promoter (red) in a pluripotent-specific way (top). Barplot of the m4C-
seq signal for each of the indicated regions in MEFs, piPSCs, and ESCs. The signal is expressed in reads per million (RPM) and represents the average value of
three biological replicates.
(F) ChIP experiments of the reprogramming factors Oct4, Sox2, and Klf4, as well as Med1 and Smc1a, on the indicated genomic regions in MEFs and piPSCs.
All of the ChIP-qPCR signals are first normalized to the input, and then expressed relative to the corresponding signal in ESCs (see also Figure S6). Error bars
indicate SD.
See also Figure S6 and Table S6.
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Genome-wide Interactions of the Nanog Locustend to colocalize in the genome (Gao et al., 2013; Kalhor et al.,
2012; Simonis et al., 2006). Notably, binding sites for the key plu-
ripotency factors Oct4, Sox2, Nanog, Esrrb, c-Myc, and Klf4
were also enriched among theNanog-interacting genes in plurip-
otent cells (Figure 7), suggesting that these proteins might be
involved in bringing coregulated pluripotency-associated genes
into physical proximity for subsequent transcriptional activation
during the induction and maintenance of pluripotency. Indeed,
previous studies documented roles for Oct4 in the maintenance708 Cell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc.of cis DNA loops around Nanog (Levasseur et al., 2008), for
c-Myc in the spatial organization of ribosomal RNA genes in
other cell types (Shiue et al., 2009), and for Klf1 in long-range in-
teractions of erythroid genes during blood cell development
(Schoenfelder et al., 2010). It is worth mentioning here that
forced expression of either of c-Myc, Nanog, Esrrb, or Klf4 pro-
teins relieves ESCs from leukemia-inhibitory-factor-dependent
growth (Festuccia et al., 2012; Jiang et al., 2008; Marks et al.,
2012; Smith and Dalton, 2010; Smith et al., 2010), suggesting
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Figure 7. Model Depicting the Dynamics of
Nanog Interactions during Differentiation
and Cellular Reprogramming
The Nanog locus engages in genome-wide
chromatin interactions in MEFs (‘‘MEF-specific
interactome’’) that are highly variable, possibly
because the Nanog gene is inactive in differen-
tiated cells. During reprogramming, the com-
plexity of interactions increases, presumably by
the cooperative action of the overexpressed
reprogramming factors and ‘‘bridging’’ factors,
including Mediator components (Med1). The
majority of interactions gained in piPSCs lead to
upregulation of associated genes immediately or
in iPSCs. Once cells reach the pluripotent state,
different and more-stable interactions are estab-
lished. These pluripotency-specific interactions
are mainly maintained by cohesin and Mediator
complexes, as well as the key pluripotency fac-
tors. Upon normal differentiation or depletion of
either Med1 or Smc1a, the Nanog interactome is
rearranged into the less-organized differentiated
state.
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Genome-wide Interactions of the Nanog Locusthat the observed interaction network and its constituents may
also be functionally connected.
We provide evidence that members of the Mediator and/or
cohesin families are responsible for about 40% of the observed
interactions in ESCs. Their depletion from ESCs resulted in a
rearrangement of chromatin from a pluripotent to a differentiated
state before the transcriptional and phenotypic onset of differen-
tiation. Similarly, their reduction during cellular reprogramming
impaired iPSC colony formation, suggesting an additional role
in establishing pluripotency. Our observation that Med1 associ-
ated physically with the overexpressed Oct4, Sox2, and Klf4
factors during reprogramming and with the corresponding
endogenous proteins in established ESCs supports this interpre-
tation and extends previous results regarding the direct interac-
tions of cohesin and Mediator subunits with Oct4 and Nanog in
ESCs (Costa et al., 2013; Nitzsche et al., 2011; Tutter et al.,
2009; van den Berg et al., 2010). Our results therefore suggest
that Mediator and cohesin components, in collaboration with
pluripotency transcription factors, play a critical role in establish-
ing and maintaining a broader 3D chromatin network centered
around Nanog and possibly other pluripotency loci (Figure 7).
We cannot exclude the possibility that Mediator and cohesin
influence iPSC formation and ESC maintenance by additional
mechanisms such as cell cycle, cell signaling (Rocha et al.,
2010), mesenchymal-to-epithelial transition (Huang et al.,
2012), and/or transcriptional regulation (Malik and Roeder,
2010; Wood et al., 2010).
Lastly, we document that the reprogramming of somatic cells
into iPSCs resets Nanog’s chromatin interactome. We show that
fibroblasts rapidly lose MEF-specific interactions upon overex-
pression of Oct4, Sox2, Klf4, and c-Myc and gradually establish
pluripotency-specific interactions. This is in accordance with the
transcriptional shutdown of the somatic program prior to the
activation of the pluripotency program as described recently
(Polo et al., 2012; Soufi et al., 2012; Stadtfeld et al., 2008). Unex-
pectedly, we detected a number of transient, reprogramming-specific contacts, which involved many pluripotency-related
genes (Figure 7). These genes might be physically brought
together with Nanog by forced reprogramming-factor expres-
sion for coordinated gene activation. The observed protein-
protein interactions of Oct4, Sox2, and Klf4 with Med1 in piPSCs
support a model whereby reprogramming factors and associ-
ated bridging factors act synergistically to orchestrate chromatin
rearrangements during reprogramming (Figure 7). However, we
cannot rule out the possibility that these interactions might be
the consequence of global chromatin changes or aberrant bind-
ing of the overexpressed transcription factors during reprogram-
ming (Soufi et al., 2012).
Collectively, our data provide a comprehensive analysis of the
genomic interactions of a key pluripotency gene and their rela-
tionship with transcription, epigenetic marks, and pluripotency-
factor binding. Our findings further suggest an important and
possibly causative role for chromatin structure in controlling
transcriptional patterns and eventually determining cell identity
in the context of pluripotency, differentiation, and cellular reprog-
ramming. Identifying the interactomes for other pluripotency loci
should allow researchers to construct an integrative view of 3D
chromatin architecture in pluripotent cells in the future.EXPERIMENTAL PROCEDURES
Cell Culture and Reprogramming
ESCs, MEF-derived iPSCs (Stadtfeld et al., 2010a), and piPSCs (Maherali
et al., 2007) were cultured as described before. MEFs were isolated from
‘‘reprogrammable’’ mice (Stadtfeld et al., 2010b) and reprogrammed in pres-
ence of 1 mg/ml doxycycline and 50 mg/ml ascorbic acid.shRNA Virus Production and Infection
The shRNA lentiviruses for Med1 and Smc1a were designed according to
a previous study (Kagey et al., 2010) and cloned into a different vector
(Addgene-pSicoR-GFP). The virus production, transduction, and reprogram-
ming of infected MEFs are described in Supplemental Experimental Proce-
dures. All the shRNA sequences used for this study are shown in Table S6.Cell Stem Cell 12, 699–712, June 6, 2013 ª2013 Elsevier Inc. 709
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The RNA-seq library construction is described in the Supplemental Experi-
mental Procedures.
Protein Coimmunoprecipation
The antibodies used for this study were as follows: Med1 (Bethyl Laboratories),
Smc1 (Bethyl Laboratories), Oct4 (Santa Cruz Biotechnology for western blot-
ting and R&D Systems for immunoprecipitation), Sox2 (R&D), Klf4 (R&D),
Nanog (Bethyl Laboratories), actin-HPRT (Abcam), Med12 (Bethyl Labora-
tories), Smc3 (Abcam), and Rad21 (Santa Cruz). The exact process is
described in the Supplemental Experimental Procedures.
ChIP
ChIP was performed as described previously (Stadtfeld et al., 2012). The anti-
bodies used were as follows: Oct4 (R&D), Sox2 (R&D), Klf4 (R&D), Med1
(Bethyl Laboratories), Smc1 (Bethyl Laboratories), immunoglobulin G (Abcam),
and Pol II phospho-Ser2 (Abcam). The primers used for the quantitative PCR
(qPCR) analysis are listed in Table S6.
3D DNA FISH and Image Analysis
3DDNA FISH analysis was performed as described previously (Xu et al., 2006).
The protocol and the bacterial artificial clones used for this study are listed in
the Supplemental Experimental Procedures.
m4C-Seq, m4C-ChIP-Seq, and 3C Analyses
4C and 3C were performed as has been previously described (Schoenfelder
et al., 2010) with some modifications, described in detail in the Supplemental
Experimental Procedures. For m4C-ChIP-seq, an immunoprecipitation step
with Med1 and Smc1 antibodies (Bethyl Laboratories) was included. The
primers used for these assays are listed in Table S6.
Bioinformatics Analyses of m4C-Seq and Associations with Public
Data Sets
See Supplemental Experimental Procedures.
ACCESSION NUMBERS
The Sequence Read Archive accession number for sequencing data reported
in this paper is SRA051554.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and six tables and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2013.04.013.
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